Influence of age on natriuretic peptides in patients with chronic heart failure: A comparison between ANP/NT-ANP and BNP/NT-proBNP

European Journal of Heart Failure

Volumn 7, Issue 1, 2005, Pages 81-86

  Hogenhuis, Jochem ^a   Voors, Adriaan A ^a   Jaarsma, Tiny ^a   Hillege, Hans L ^a   Boomsma, Frans ^b   Van Veldhuisen, Dirk J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Age; ANP; BNP; Heart failure

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR;

AGE; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 11844293448     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2004.03.014     Document Type: Article

References (21)

1. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N. Engl. J. Med. 347:2002;161-167
2. McDonagh T.A., Robb S.D., Murdoch D.R., et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet. 351:1998;9-13
3. Morrison L.K., Harrison A., Krishnaswamy P., Kazanegra R., Clopton P., Maisel A. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J. Am. Coll. Cardiol. 39:2002;202-209
4. Dao Q., Krishnaswamy P., Kazanegra R., et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J. Am. Coll. Cardiol. 37:2001;379-385
5. Tsutamoto T., Wada A., Maeda K., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 96:1997;509-516
6. Cowie M.R., Struthers A.D., Wood D.A., et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet. 350:1997;1349-1353
7. Richards A.M., Nicholls M.G., Yandle T.G., et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation. 97:1998;1921-1929
8. Clerico A., Del Ry S., Maffei S., Prontera C., Emdin M., Giannessi D. The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex. Clin. Chem. Lab. Med. 40:2002;371-377
9. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., Mahoney D.W., Bailey K.R., Burnett J.C. Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J. Am. Coll. Cardiol. 40:2002;976-982
10. Wang T.J., Larson M.G., Levy D., et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am. J. Cardiol. 90:2002;254-258
11. Dutka D.P., Olivotto I., Ward S., Oakley C.M., Impallomeni M., Cleland J.G. Effects of aging on neuroendocrine activation in subjects and patients in the presence and absence of heart failure with left ventricular systolic dysfunction. Am. J. Cardiol. 77:1996;1197-1201
12. van Veldhuisen D.J., Boomsma F., de Kam P.J., et al. Influence of age on neurohormonal activation and prognosis in patients with chronic heart failure. Eur. Heart J. 19:1998;753-760
13. Luchner A., Brockel U., Muscholl M., et al. Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: a population-based study. Cardiovasc. Res. 53:2002;720-727
14. Hampton J.R., van Veldhuisen D.J., Kleber F.X., et al. Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second prospective randomised study of ibopamine on mortality and efficacy (PRIME II) Investigators. Lancet. 349:1997;971-977
15. Rosmalen F.M., Tan A.C., Tan H.S., Benraad T.J. A sensitive radioimmunoassay of atrial natriuretic peptide in human plasma, using a tracer with an immobilized glycouril agent. Clin. Chim. Acta. 165:1987;331-340
16. Tan A.C., Rosmalen F.M., Hofman J.A., Kloppenborg P.W., Benraad T.J. Evaluation of a direct assay for atrial natriuretic peptide. Clin. Chim. Acta. 179:1989;1-12
17. Bhaggoe U.M., Boomsma F.F., Admiraal P.J., et al. Stability of human plasma atrial natriuretic peptide during storage at -80 degrees C. Clin. Chim. Acta. 223:1993;179-184
18. Boomsma F., Bhaggoe U.M., Man in 't Veld A.J., Schalekamp M.A. Comparison of N-terminal pro-atrial natriuretic peptide and atrial natriuretic peptide in human plasma as measured with commercially available radioimmunoassay kits. Clin. Chim. Acta. 252:1996;41-49
19. Kato J., Kitamura K., Uemura T., et al. Plasma levels of adrenomedullin and atrial and brain natriuretic peptides in the general population: their relations to age and pulse pressure. Hypertens. Res. 25:2002;887-892
20. Raymond I., Groenning B.A., Hildebrandt P.R., et al. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart. 89:2003;745-751
21. Masson S., Vago T., Baldi G., et al. Comparative measurement of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in ambulatory patients with heart failure. Clin. Chem. Lab. Med. 40:2002;761-763